<qa>  What is the IMRT boost for intermediate risk patients?Patients with locally confined prostate adenocarcinoma clinical stage T1c - T2bN0M0, Gleason score 7, PSA 20 ngml are assigned to one of two treatment arms. Low risk patients T1c-T2a and PSA 10 ngml and Gleason Score 6 or less will receive 5 fractions of 8.0 Gy for a total of 40 Gy. Intermediate risk patients T2b or PSA 10 ngml orGleason Score 7 will receive 1.8 Gy of IMRT for 25 fractions over 5 weeks for a total of 45 Gy. They will then receive a boost consisting of 4, 5.5 Gy fractions after IMRT for a total of 22 Gy. 